Cancers, Vol. 13, Pages 1936: Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)
In conclusion, NET G3 with FOLFOX showed the highest ORR, and with TEM/CAP showed the longest PFS. Further prospective evaluation of the optimal therapeutic strategy for this tumor entity is needed.
Source: Cancers - Category: Cancer & Oncology Authors: Leonidas Apostolidis Arianna Dal Buono Elettra Merola Henning Jann Dirk J äger Bertram Wiedenmann Eva Caroline Winkler Marianne Pavel Tags: Article Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | Germany Health | Neurology | Palliative | Temodar | Xeloda